Related Experiment Video
Updated: May 9, 2026
09:37
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Abstract:
Somatic ERBB3 hot-spot mutations promote oncogenic signaling in a subset of human tumors.
Insights
Somatic mutations in ERBB3 hotspots drive cancer growth in some individuals. These alterations activate oncogenic signaling pathways, offering potential therapeutic targets for specific human tumors.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The Epidermal Growth Factor Receptor (EGFR) family plays a crucial role in cell growth and differentiation.
- ERBB3 (also known as HER3) is a member of the EGFR family and is known to interact with other family members.
- Dysregulation of ERBB3 signaling has been implicated in various cancers.
Purpose of the Study:
- To investigate the role of somatic ERBB3 mutations in human cancers.
- To identify specific hot-spot mutations within ERBB3 that contribute to oncogenesis.
- To understand the downstream signaling consequences of these ERBB3 mutations.
Main Methods:
- Somatic mutation analysis of ERBB3 in a large cohort of human tumors.
- Functional assays to assess the impact of identified mutations on ERBB3 signaling.
- Analysis of downstream signaling pathways, including PI3K/AKT and MAPK.
Main Results:
- Identified recurrent hot-spot mutations in the ERBB3 gene in a subset of human tumors.
- Demonstrated that these ERBB3 mutations lead to constitutive activation of oncogenic signaling pathways.
- Showcased increased tumor cell proliferation and survival in vitro and in vivo models harboring ERBB3 mutations.
Conclusions:
- Somatic ERBB3 hot-spot mutations are oncogenic drivers in specific human tumor types.
- These mutations activate critical pro-tumorigenic signaling cascades.
- Targeting ERBB3 or its downstream pathways may represent a therapeutic strategy for ERBB3-mutated cancers.
Related Concept Videos
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...